Chondroadherin prevents bone loss and inhibits tumor growth in animal models of osteoporosis and cancer-induced bone disease
✍ Scribed by N. Rucci; M. Capulli; O.K. Olstad; K.M. Gautvik; L. Haglund; D. Heinegård; A. Teti
- Book ID
- 119204240
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 59 KB
- Volume
- 51
- Category
- Article
- ISSN
- 8756-3282
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Objective. Inhibitors of prostaglandin production, such as nonsteroidal antiinflammatory drugs (NSAIDs), and pharmacologic nitric oxide (NO) donors, such as organic nitrates, have been suggested to protect against bone loss in both humans and experimental animals. Recently, a new class of nitrosylat
## Abstract The systemic balance of angiogenic and anti‐angiogenic factors has been proposed to play a key‐role in primary tumor growth dependent growth suppression of secondary tumors. Despite the importance of the organ microenvironment to angiogenesis and microcirculation, the influence of a pri